Cybin Inc (CYBN)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Cybin Inc Stock (CYBN) Company Profile

Healthcare (1164)

Biotechnology (651)

908 764 8385

100 King Street West, Suite 5600, Toronto

Prossima data di guadagno

Ultimi documenti SEC

CYBN's Discussions on Twitter

Confronta CYBN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CYBN Cybin Inc	7.99	185.19M	0	-52.07M	-44.93M	-0.2077
VRTX Vertex Pharmaceuticals Inc	469.65	121.28B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	563.10	60.96B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	328.81	42.77B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	591.99	36.21B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	291.47	32.08B	3.81B	-644.79M	-669.77M	-6.24

Cybin Inc Stock (CYBN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-13	Iniziato	Guggenheim	Buy
2021-11-19	Downgrade	Maxim Group	Buy → Hold

Cybin Inc Borsa (CYBN) Ultime notizie

Cybin Inc Azioni (CYBN) Dati Finanziari

Cybin Inc (CYBN)

Cybin Inc Stock (CYBN) Company Profile

Confronta CYBN con altri titoli

Cybin Inc Stock (CYBN) Upgrades & Downgrades

Cybin Inc Borsa (CYBN) Ultime notizie

What are the technical indicators suggesting about Cybin Inc.Access high-yield investment alerts now - jammulinksnews.com

Should I hold or sell Cybin Inc. stock in 2025Extraordinary performance - jammulinksnews.com

How Cybin Inc. stock performs during market volatilitySolid Return Trade Selections - Metal.it

What analysts say about Cybin Inc. stockSuperior portfolio returns - PrintWeekIndia

Cybin Inc. Stock Analysis and ForecastFree Capital Efficiency Planning - PrintWeekIndia

Is Cybin Inc. a good long term investmentExceptional growth trajectory - PrintWeekIndia

Cybin, Inc: CYB003 Vs. GH001Duration, Durability and Protocol Execution - Smartkarma

What drives Cybin Inc. stock pricePowerful market insights - PrintWeekIndia

Will Cybin Inc. stock benefit from AI tech trendsFree Predictions - jammulinksnews.com

I can have 5% loss. - AInvest

(CYBN) Proactive Strategies - news.stocktradersdaily.com

High-Risk, High-Reward Stocks With Serious Momentum: 5 Stocks to Consider - AInvest

Cybin Inc: CYB003 Phase 3 Program Continues to Progress on Plan - Smartkarma

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money

Wall Street Analysts See an 831.44% Upside in Cybin Inc. (CYBN): Can the Stock Really Move This High? - Yahoo Finance

UK MHRA approves Cybin’s trial of CYB003 for major depressive disorder - Yahoo Finance

Three High-Risk, High-Reward Stocks in AI, Biotech, and Autonomous Vehicles - AInvest

Cybin's EMBRACE Study: A Pivotal Step in Psychedelic-Driven Mental Healthcare Innovation - AInvest

Cybin receives UK MHRA approval to commence EMBRACE study - TipRanks

Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Cybin Secures UK Approval for Pivotal Depression Study - TipRanks

Cybin receives UK approval for second pivotal depression study By Investing.com - Investing.com India

Cybin receives UK approval for second pivotal depression study - Investing.com

Cybin Receives UK MHRA Approval To Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 For The Adjunctive Treatment Of Major Depressive Disorder - TradingView

Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - FinancialContent

3 High-Risk, High-Reward Stocks With Explosive Upside - MarketBeat

Three High-Risk, High-Reward Stocks with Explosive Upside: Rezolve AI, Aurora Innovation, and Cybin Inc. - AInvest

Cybin, Inc.CYB003 Vs. Other Aspiring Novel Depression Treatments - Smartkarma

Cybin Inc. Expands Market Strategy with New SEC Filing - The Globe and Mail

Cybin, Inc: Not All Psychedelic Treatments for Depression Are Created Equal - Smartkarma

Cybin Inc Azioni (CYBN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CYBN